Heating the patient: a promising approach?
/in Hyperthermia, International Publications /von 2002-08-01 / Ann. Oncol. 2002 Aug;13(8):1173-84Whole-body hyperthermia: a review of theory, design and application
/in Hyperthermia, International Publications /von 2002-07-01 / Perfusion 2002 Jul;17(4):279-90Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
/in Breast Cancer, Colorectal Cancer, Glioblastoma, International Publications, Newcastle Disease Virus /von 2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
/in Cervical Cancer, Dendritic Cells, International Publications /von 2002-05-30 / N. Engl. J. Med. 2002 May;346(22):1752-3Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
/in Chronic Virus Hepatitis, International Publications /von 2002-05-01 / Hepatol. Res. 2002 May;23(1):38-47A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models
/in Hyperthermia, International Publications /von 2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-66Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
/in International Publications, Newcastle Disease Virus /von 2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-66Optimizing dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-04-01 / Blood 2002 Apr;99(7):2512-7IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de